Skip to Content

ZA 66 125 mg (Divalproex Sodium Delayed-Release (Sprinkle) 125 mg)

Pill with imprint ZA 66 125 mg is Blue & White, Capsule-shape and has been identified as Divalproex Sodium Delayed-Release (Sprinkle) 125 mg. It is supplied by Zydus Pharmaceuticals.

Divalproex sodium is used in the treatment of bipolar disorder; migraine prevention; mania; epilepsy; borderline personality disorder (and more), and belongs to the drug class fatty acid derivative anticonvulsants. When treating epilepsy and manic episodes associated with bipolar disorder: There is positive evidence of human fetal risk during pregnancy. When treating migraine: Not for use in pregnancy. Divalproex sodium 125 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for ZA 66 125 mg

Divalproex Sodium Delayed-Release (Sprinkle)

Imprint:
ZA 66 125 mg
Strength:
125 mg
Color:
Blue & White
Size:
22.00 mm
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Fatty acid derivative anticonvulsants
Pregnancy Category:
D - Positive evidence of risk - When treating epilepsy and manic episodes associated with bipolar disorder
X - Not for use in pregnancy - When treating migraine
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Zydus Pharmaceuticals
Inactive Ingredients:
FD&C Blue No. 1
hypromelloses
silicon dioxide
triethyl citrate
methacrylic acid
sodium lauryl sulfate
gelatin
magnesium silicate
titanium dioxide
microcrystalline cellulose
Note: Inactive ingredients may vary.

Other Labelers / Repackagers:

NDC CodeLabeler / Repackager
68084-0313 Amerisource Health Services

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide